- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 109.16M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $969.89M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $973.07M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $12.98M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $12.07M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $74.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $107.49M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.48B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.49B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $266.63M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $285.8M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.53B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.44B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $413.45M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $449.82M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.93B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 112.31M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $48.97M |
| Capex | Q1 2025 · Mar 31, 2024 | $10.62M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $70.35M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $36.47M |
| Revenue | Q1 2025 · Mar 31, 2024 | $500.69M |